Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
 

Testicular cancer survival statistics

One-, five- and ten-year survival statistics for testicular cancer by age and trends over time are presented here. There are also data by geography and by stage at diagnosis. The ICD code for testicular cancer is ICD-10 C62.

The statistics on these pages give an overall picture of survival. Unless otherwise stated, the statistics include all male adults diagnosed with testicular cancer, at all ages, stages and co-morbidities. The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics. If you are a patient, you will probably find our CancerHelp pages more relevant and useful.

The latest survival statistics available for testicular cancer in England are 2005-2009 (followed up to 2010). Find out why these are the latest statistics available.

 

One-, five- and ten-year survival

Age-standardised relative survival for testicular cancer in England during 2005-2009 shows that 98% of men are expected to survive their disease for at least one year, falling only slightly to 97% (not age-standardised) surviving five years or more (Table 3.1).1,2 Broadly similar figures have been reported for Wales, Scotland and Northern Ireland.3-5

Table 3.1: Testicular Cancer (C62), Age-Standardised One-, Five- and Ten-Year Relative Survival, Adults (Aged 15-99), England 2005-2009 and 2009

One-Year Five-Year Ten-Year
Sex 2005-2009 2005-2009 2009
Men 98.0 97.2 96.0

Download this table XLS (33KB) PPT (121KB) PDF (179KB)

Five-year survival is not age-standardised
Ten-year survival has been predicted for patients diagnosed in 2009 (using the hybrid approach)

For testicular cancer, survival does not fall much beyond five years after diagnosis, so for testicular cancer five-year survival effectively represents a ‘cure’ rate. (Table 3.1).1,2

The five-year relative survival for testicular cancer is the highest of the 21 most common cancers in England.1 Like most cancers, when caught at an early stage treatment is much more effective. However, testicular cancer survival is extremely high for all stages of the disease. In fact, testicular cancer has become a model for a curable neoplasm.6

section reviewed 29/07/13
section updated 29/07/13

 

By age

As with nearly all cancers, relative survival for testicular cancer is higher in younger men, even after taking account of the higher background mortality in older people. The reasons for this are likely to include a combination of better general health, more effective response to treatment and earlier diagnosis in younger people overall. Differences in underlying tumour biology may also play a part for some cancer sites.

The five-year relative survival for testicular cancer in men in England during 2005-2009 ranged from 98% in 15-39 year olds to 59% in 80-99 year olds (Figure 3.1).2

Figure 3.1: Testicular Cancer (C62), Five-Year Relative Survival by Age, England 2005-2009

surv_5yr_age_testis.swf

Download this chart XLS (46KB) PPT (127KB) PDF (41KB)

section reviewed 09/08/12
section updated 09/08/12

 

Trends over time

As with the majority of cancers, relative survival for testicular cancer is improving. This can be attributed improvements in treatment. In particular the drug cisplaten.

One-year relative survival for testicular cancer in England increased from 83% during 1971-1975 to 98% during 2005-2009 (Figure 3.2).1,2 Five- and Ten-Year survival showed similar improvements. Five-year relative survival for testicular cancer in England increased from 70% during 1971-1975 to 97% (not age-standardised) during 2005-2009. Ten-year survival for men diagnosed with testicular cancer increased from 68% during 1971-1975 to a predicted 96% in England in 2009. 

Figure 3.2: Testicular Cancer (C62), Age-Standardised One-, Five- and Ten-Year Relative Survival, England 1971-2009

surv_1_5_10yrtr_testis.swf

Download this chart XLS (49KB) PPT (131KB) PDF (55KB)

section reviewed 29/07/13
section updated 29/07/13

 

In Europe

International comparisons of one and five-year survival for men in England and Wales diagnosed with testicular cancer in 1995-99 show testicular cancer is one of the few cancers for which survival in the UK equal or even exceed those recorded in the rest of Europe.7

section reviewed 25/06/12
section updated 25/06/12

 

By stage at diagnosis

Survival for testicular cancer is related to stage of the disease at diagnosis. The majority (73%) of patients present at Stage I.10 More people are diagnosed at an early stage (86% are diagnosed at Stages I or II) than an advanced stage.

One-year survival for testicular cancer is highest for patients presenting at Stage I, with 100% of men surviving their disease for at least one year (Figure 3.3).10 Survival is significantly lower for those diagnosed with Stage III and IV disease (87%). As very few patients are diagnosed at Stage III and IV, however, the one-year survival statistics have wide confidence limits and should therefore be interpreted with caution. 

Figure 3.3 Testicular Cancer (C62), One-Year Relative Survival by Stage, Adults (Aged 15-99 Years), Former Anglia Cancer Network, 2006-2010

surv_1yr_stage_testis.swf

Download this chart XLS (46KB) PPT (135KB) PDF (31KB)

Note: relative survival can be greater than 100% because it accounts for background mortality. A relative survival figure greater than 100 indicates that people diagnosed have a better chance of surviving one or five years after diagnosis than the general population.

Five-year survival for testicular cancer is similarly related to the stage of the disease at diagnosis. Five-year survival ranges from 101% at Stage I to 84% at Stage III and IV (Figure 3.4).10 Unusually, five-year survival is not significantly lower than one-year survival across all known stage groups. 

Figure 3.4 Testicular Cancer (C62), Five-Year Relative Survival Rates by Stage, Adults (Aged 15-99 Years), Former Anglia Cancer Network, 2001-2005

surv_5yr_stage_testis.swf

Download this chart XLS (47KB) PPT (136KB) PDF (33KB)

Note: relative survival can be greater than 100% because it accounts for background mortality. A relative survival figure greater than 100 indicates that people diagnosed have a better chance of surviving one or five years after diagnosis than the general population.  

Survival by stage is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past; this is improving, however, and plans for a nationally consistent dataset in England are underway.11 In the meantime, survival by stage is available for the former Anglia Cancer Network in the East of England for the period 2006-2010.10 Anglia covers around 5% of the population of England and may not be representative of the country as a whole due to differences in underlying demographic factors (such as age, deprivation or ethnicity), as well as variation in local healthcare provision standards and policies. Nonetheless, the Anglia data enable valuable comparisons between stage at diagnosis and cancer survival to be made.

section reviewed 29/07/13
section updated 29/07/13

No Error

Rate this page:
Submit rating
Rated 5 out of 5 based on 5 votes
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

Visit our A-Z topic pages

 

References for testicular cancer survival

  1. Survival estimates were provided by the Cancer Research UK Cancer Survival Group. London School of Hygiene and Tropical Medicine on request, December 2012. http://www.lshtm.ac.uk/eph/ncde/cancersurvival/
  2. For data for 2005-2009: Office for National Statistics (ONS). Cancer survival in England: Patients diagnosed 2005-2009 and followed up to 2010. London: ONS; 2011.
  3. Welsh Cancer Intelligence and Surveillance Unit (WCISU). Cancer Survival Trends in Wales 1985-2004. Cardiff: WCISU; 2010.
  4. Information Services Division Scotland (ISD Scotland). Cancer Statistics. Male genital organs. Accessed September 2011.
  5. Northern Ireland Cancer Registry (NICR). Cancer Survival Online Statistics. Testis. Accessed September 2011.
  6. Einhorn LH. Treatment of testicular cancer: a new and improved model. J Clin Oncol 1990;8(11):1777-81.
  7. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-91.
  8. Jones RH, Vasey PA. Part II: testicular cancer-management of advanced disease. Lancet Oncol 2003;4(12):738-47.
  9. Masters JR, Köberle B. Curing metastatic cancer: lessons from testicular germ-cell tumours. Nat Rev Cancer 2003;3(7):517-25.
  10. The National Cancer Registration Service, Eastern Office. Personal communication.
  11. Department of Health. Improving outcomes: a strategy for cancer. London: Department of Health; 2011.
Updated: 29 July 2013